Correction to: Innovative radiation oncology Together—Precise, Personalized, Human

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1439-099X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Correction to: Innovative radiation oncology Together—Precise, Personalized, Human ; volume:197 ; number:12 ; day:3 ; month:11 ; year:2021 ; pages:1049-1050 ; date:12.2021
Strahlentherapie und Onkologie ; 197, Heft 12 (3.11.2021), 1049-1050, 12.2021

Creator: Krug, David
Hecht, Markus
Ebert, Nadja
Mäurer, Matthias
Fleischmann, Daniel F.
Fokas, Emmanouil
Straube, Christoph
Nicolay, Nils
Hörner-Rieber, Juliane
Schmitt, Daniela
von Neubeck, Cläre
Zamboglou, Constantinos
Sperk, Elena
Kaul, David
Hess, Julia
Corradini, Stefanie
Seidel, Clemens
Gani, Cihan
Baues, Christian
Frey, Benjamin
Blanck, Oliver
Gauer, Tobias
Niyazi, Karim-Maximilian

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00066-021-01869-z

URN: urn:nbn:de:101:1-2022012907362776601587

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Krug, David
Hecht, Markus
Ebert, Nadja
Mäurer, Matthias
Fleischmann, Daniel F.
Fokas, Emmanouil
Straube, Christoph
Nicolay, Nils
Hörner-Rieber, Juliane
Schmitt, Daniela
von Neubeck, Cläre
Zamboglou, Constantinos
Sperk, Elena
Kaul, David
Hess, Julia
Corradini, Stefanie
Seidel, Clemens
Gani, Cihan
Baues, Christian
Frey, Benjamin
Blanck, Oliver
Gauer, Tobias
Niyazi, Karim-Maximilian
SpringerLink (Online service)

Other Objects (12)

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation

Grabstein

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Immune biological rationales for the design of combined radio- and immunotherapies

Hochschulschrift

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

Identification and validation of immunerelated biomarkers for cancer patients treated with immunotherapy and/or radio(chemo)therapy

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation

Grabstein

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Immune biological rationales for the design of combined radio- and immunotherapies

Hochschulschrift

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

Identification and validation of immunerelated biomarkers for cancer patients treated with immunotherapy and/or radio(chemo)therapy

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation

Grabstein

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Immune biological rationales for the design of combined radio- and immunotherapies

Hochschulschrift

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

Identification and validation of immunerelated biomarkers for cancer patients treated with immunotherapy and/or radio(chemo)therapy

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: Innovative radiation oncology Together—Precise, Personalized, Human

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation

Grabstein

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Immune biological rationales for the design of combined radio- and immunotherapies

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

Identification and validation of immunerelated biomarkers for cancer patients treated with immunotherapy and/or radio(chemo)therapy

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation

Grabstein

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Immune biological rationales for the design of combined radio- and immunotherapies

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

Identification and validation of immunerelated biomarkers for cancer patients treated with immunotherapy and/or radio(chemo)therapy

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation

Grabstein

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group

Immune biological rationales for the design of combined radio- and immunotherapies

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

Identification and validation of immunerelated biomarkers for cancer patients treated with immunotherapy and/or radio(chemo)therapy

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Boost und Hypofraktionierung beim DCIS

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Enzalutamid versus aktive Überwachung bei Patienten mit Low-risk-Prostatakarzinom

Related objects

Reset password